{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:57:06Z","timestamp":1762459026061},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,3,19]],"date-time":"2012-03-19T00:00:00Z","timestamp":1332115200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.2119\/molmed.2011.00480","type":"journal-article","created":{"date-parts":[[2013,1,7]],"date-time":"2013-01-07T16:06:26Z","timestamp":1357574786000},"page":"1281-1291","source":"Crossref","is-referenced-by-count":53,"title":["Distinct Innate Immunity Pathways to Activation and Tolerance in Subgroups of Chronic Lymphocytic Leukemia with Distinct Immunoglobulin Receptors"],"prefix":"10.1186","volume":"18","author":[{"given":"Stavroula","family":"Ntoufa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Vardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikos","family":"Papakonstantinou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achilles","family":"Anagnostopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassiliki","family":"Aleporou-Marinou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chrysoula","family":"Belessi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Ghia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Caligaris-Cappio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Muzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kostas","family":"Stamatopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,19]]},"reference":[{"key":"18091281_CR1","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1182\/blood-2010-07-155663","volume":"117","author":"N Chiorazzi","year":"2010","unstructured":"Chiorazzi N, Ferrarini M. (2010) Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. Blood. 117:1781\u201391.","journal-title":"Blood"},{"key":"18091281_CR2","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1146\/annurev.immunol.21.120601.141018","volume":"21","author":"N Chiorazzi","year":"2003","unstructured":"Chiorazzi N, Ferrarini M. (2003) B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu. Rev. Immunol. 21:841\u201394.","journal-title":"Annu. Rev. Immunol."},{"key":"18091281_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1182\/blood-2006-03-012948","volume":"109","author":"K Stamatopoulos","year":"2007","unstructured":"Stamatopoulos K, et al. (2007) Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood. 109:259\u201370.","journal-title":"Blood"},{"key":"18091281_CR4","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1182\/blood-2007-07-099564","volume":"111","author":"F Murray","year":"2008","unstructured":"Murray F, et al. (2008) Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood. 111:1524\u201333.","journal-title":"Blood"},{"key":"18091281_CR5","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1365-2141.2008.07469.x","volume":"144","author":"R Bomben","year":"2009","unstructured":"Bomben R, et al. (2009) Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study. Br. J. Haematol. 144:492\u2013506.","journal-title":"Br. J. Haematol."},{"key":"18091281_CR6","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1172\/JCI3009","volume":"102","author":"F Fais","year":"1998","unstructured":"Fais F, et al. (1998) Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J. Clin. Invest. 102:1515\u201325.","journal-title":"J. Clin. Invest."},{"key":"18091281_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/leu.2009.186","volume":"24","author":"N Darzentas","year":"2010","unstructured":"Darzentas N, et al. (2010) A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence. Leukemia. 24:125\u201332.","journal-title":"Leukemia"},{"key":"18091281_CR8","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","volume":"94","author":"RN Damle","year":"1999","unstructured":"Damle RN, et al. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 94:1840\u201347.","journal-title":"Blood"},{"key":"18091281_CR9","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","volume":"94","author":"TJ Hamblin","year":"1999","unstructured":"Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 94:1848\u201354.","journal-title":"Blood"},{"key":"18091281_CR10","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1056\/NEJMra041720","volume":"352","author":"N Chiorazzi","year":"2005","unstructured":"Chiorazzi N, Rai KR, Ferrarini M. (2005) Chronic lymphocytic leukemia. N. Engl. J. Med. 352:804\u201315.","journal-title":"N. Engl. J. Med."},{"key":"18091281_CR11","unstructured":"Belessi C, Stamatopoulos K. (2010) Stereotyped B-cell receptors in chronic lymphocytic leukemia. In: Stamatopoulos K GP, Rosenquist R, et al. (ed.) WKHealth Books, Milan, Italy, pp. 119\u201334."},{"key":"18091281_CR12","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1182\/blood-2007-11-125450","volume":"111","author":"A Lanemo Myhrinder","year":"2008","unstructured":"Lanemo Myhrinder A, et al. (2008) A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. Blood. 111:3838\u201348.","journal-title":"Blood"},{"key":"18091281_CR13","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2119\/2008-00102.Catera","volume":"14","author":"R Catera","year":"2008","unstructured":"Catera R, et al. (2008) Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation. Mol. Med. 14:665\u201374.","journal-title":"Mol. Med."},{"key":"18091281_CR14","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.1182\/blood-2008-06-162024","volume":"112","author":"CC Chu","year":"2008","unstructured":"Chu CC, et al. (2008) Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA. Blood. 112:5122\u20139.","journal-title":"Blood"},{"key":"18091281_CR15","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1182\/blood-2009-01-197822","volume":"114","author":"T Seiler","year":"2009","unstructured":"Seiler T, et al. (2009) Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells. Blood. 114:3615\u201324.","journal-title":"Blood"},{"key":"18091281_CR16","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1182\/blood-2009-09-244251","volume":"115","author":"CC Chu","year":"2010","unstructured":"Chu CC, et al. (2010) Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin. Blood. 115:3907\u201315.","journal-title":"Blood"},{"key":"18091281_CR17","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","volume":"124","author":"S Akira","year":"2006","unstructured":"Akira S, Uematsu S, Takeuchi O. (2006) Pathogen recognition and innate immunity. Cell. 124:783\u2013801.","journal-title":"Cell"},{"key":"18091281_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","volume":"20","author":"CA Janeway Jr.","year":"2002","unstructured":"Janeway CA Jr, Medzhitov R. (2002) Innate immune recognition. Annu. Rev. Immunol. 20:197\u2013216.","journal-title":"Annu. Rev. Immunol."},{"key":"18091281_CR19","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.coi.2005.02.007","volume":"17","author":"T Kawai","year":"2005","unstructured":"Kawai T, Akira S. (2005) Pathogen recognition with Toll-like receptors. Curr. Opin. Immunol. 17:338\u201344.","journal-title":"Curr. Opin. Immunol."},{"key":"18091281_CR20","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/ni1412","volume":"7","author":"JH Fritz","year":"2006","unstructured":"Fritz JH, Ferrero RL, Philpott DJ, Girardin SE. (2006) Nod-like proteins in immunity, inflammation and disease. Nat. Immunol. 7:1250\u20137.","journal-title":"Nat. Immunol."},{"key":"18091281_CR21","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1182\/blood-2002-11-3569","volume":"101","author":"NL Bernasconi","year":"2003","unstructured":"Bernasconi NL, Onai N, Lanzavecchia A. (2003) A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood. 101:4500\u20134.","journal-title":"Blood"},{"key":"18091281_CR22","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1182\/blood-2002-11-3355","volume":"102","author":"E Bourke","year":"2003","unstructured":"Bourke E, Bosisio D, Golay J, Polentarutti N, Mantovani A. (2003) The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. Blood. 102:956\u201363.","journal-title":"Blood"},{"key":"18091281_CR23","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1084\/jem.20071250","volume":"204","author":"A Meyer-Bahlburg","year":"2007","unstructured":"Meyer-Bahlburg A, Khim S, Rawlings DJ. (2007) B cell intrinsic TLR signals amplify but are not required for humoral immunity. J. Exp. Med. 204:3095\u2013101.","journal-title":"J. Exp. Med."},{"key":"18091281_CR24","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/eji.200535744","volume":"36","author":"CR Ruprecht","year":"2006","unstructured":"Ruprecht CR, Lanzavecchia A. (2006) Toll-like receptor stimulation as a third signal required for activation of human naive B cells. Eur. J. Immunol. 36:810\u20136.","journal-title":"Eur. J. Immunol."},{"key":"18091281_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1189\/jlb.0210061","volume":"89","author":"T Petterson","year":"2011","unstructured":"Petterson T, et al. (2011) Effects of NOD-like receptors in human B lymphocytes and crosstalk between NOD1\/NOD2 and Toll-like receptors. J. Leukoc. Biol. 89:177\u201387.","journal-title":"J. Leukoc. Biol."},{"key":"18091281_CR26","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/416603a","volume":"416","author":"EA Leadbetter","year":"2002","unstructured":"Leadbetter EA, et al. (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature. 416:603\u20137.","journal-title":"Nature"},{"key":"18091281_CR27","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1084\/jem.20050630","volume":"202","author":"CM Lau","year":"2005","unstructured":"Lau CM, et al. (2005) RNA-associated autoantigens activate B cells by combined B cell antigen receptor\/Toll-like receptor 7 engagement. J. Exp. Med. 202:1171\u20137.","journal-title":"J. Exp. Med."},{"key":"18091281_CR28","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.4049\/jimmunol.0900495","volume":"183","author":"JS Poovassery","year":"2009","unstructured":"Poovassery JS, Vanden Bush TJ, Bishop GA. (2009) Antigen receptor signals rescue B cells from TLR tolerance. J. Immunol. 183:2974\u201383.","journal-title":"J. Immunol."},{"key":"18091281_CR29","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3324\/haematol.10975","volume":"92","author":"C Grandjenette","year":"2007","unstructured":"Grandjenette C, Kennel A, Faure GC, Bene MC, Feugier P. (2007) Expression of functional tolllike receptors by B-chronic lymphocytic leukemia cells. Haematologica. 92:1279\u201381.","journal-title":"Haematologica"},{"key":"18091281_CR30","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/ijc.24832","volume":"126","author":"D Rozkova","year":"2010","unstructured":"Rozkova D, et al. (2010) Toll-like receptors on B-CLL cells: expression and functional consequences of their stimulation. Int. J. Cancer. 126:1132\u201343.","journal-title":"Int. J. Cancer."},{"key":"18091281_CR31","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/j.1365-2141.2008.07475.x","volume":"144","author":"M Muzio","year":"2009","unstructured":"Muzio M, et al. (2009) Expression and function of toll like receptors in chronic lymphocytic leukaemia cells. Br. J. Haematol. 144:507\u201316.","journal-title":"Br. J. Haematol."},{"key":"18091281_CR32","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.3324\/haematol.2011.044792","volume":"96","author":"E Arvaniti","year":"2011","unstructured":"Arvaniti E, et al. (2011) Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenetic significance in specific subsets of patients. Haematologica. 96:1644\u201352.","journal-title":"Haematologica"},{"key":"18091281_CR33","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","volume":"111","author":"M Hallek","year":"2008","unstructured":"Hallek M, et al. (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 111:5446\u201356.","journal-title":"Blood"},{"key":"18091281_CR34","doi-asserted-by":"publisher","first-page":"D1006","DOI":"10.1093\/nar\/gkn838","volume":"37","author":"MP Lefranc","year":"2009","unstructured":"Lefranc MP, et al. (2009) IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res. 37: D1006\u201312.","journal-title":"Nucleic Acids Res."},{"key":"18091281_CR35","doi-asserted-by":"publisher","first-page":"W503","DOI":"10.1093\/nar\/gkn316","volume":"36","author":"X Brochet","year":"2008","unstructured":"Brochet X, Lefranc MP, Giudicelli V. (2008) IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 36: W503\u20138.","journal-title":"Nucleic Acids Res."},{"key":"18091281_CR36","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1182\/blood.V95.3.999.003k10_999_1006","volume":"95","author":"T Decker","year":"2000","unstructured":"Decker T, et al. (2000) Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells. Blood. 95:999\u20131006.","journal-title":"Blood"},{"key":"18091281_CR37","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1172\/JCI19399","volume":"113","author":"F Ghiotto","year":"2004","unstructured":"Ghiotto F, et al. (2004) Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J. Clin. Invest. 113:1008\u201316.","journal-title":"J. Clin. Invest."},{"key":"18091281_CR38","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1158\/0008-5472.CAN-06-2381","volume":"67","author":"Y Shi","year":"2007","unstructured":"Shi Y, White D, He L, Miller RL, Spaner DE. (2007) Toll-like receptor-7 tolerizes malignant B cells and enhances killing by cytotoxic agents. Cancer Res. 67:1823\u201331.","journal-title":"Cancer Res."},{"key":"18091281_CR39","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/sj.leu.2404417","volume":"21","author":"PG Longo","year":"2007","unstructured":"Longo PG, et al. (2007) The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease. Leukemia 21:110\u201320.","journal-title":"Leukemia"},{"key":"18091281_CR40","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1182\/blood-2002-06-1822","volume":"101","author":"S Lanham","year":"2003","unstructured":"Lanham S, et al. (2003) Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia. Blood. 101:1087\u201393.","journal-title":"Blood"},{"key":"18091281_CR41","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1182\/blood-2006-11-056648","volume":"109","author":"CI Mockridge","year":"2007","unstructured":"Mockridge CI, et al. (2007) Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status. Blood. 109:4424\u201331.","journal-title":"Blood"},{"key":"18091281_CR42","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1182\/blood-2007-09-111344","volume":"112","author":"M Muzio","year":"2008","unstructured":"Muzio M, et al. (2008) Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy. Blood. 112:188\u201395.","journal-title":"Blood"},{"key":"18091281_CR43","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1182\/blood-2004-07-2606","volume":"105","author":"P Ghia","year":"2005","unstructured":"Ghia P, et al. (2005) Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. Blood. 105:1678\u201385.","journal-title":"Blood"},{"key":"18091281_CR44","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1158\/1078-0432.CCR-05-2164","volume":"12","author":"KN Potter","year":"2006","unstructured":"Potter KN, et al. (2006) Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia. Clin. Cancer Res. 12:1672\u20139.","journal-title":"Clin. Cancer Res."},{"key":"18091281_CR45","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s000180300026","volume":"60","author":"YJ Jang","year":"2003","unstructured":"Jang YJ, Stollar BD. (2003) Anti-DNA antibodies: aspects of structure and pathogenicity. Cell Mol. Life Sci. 60:309\u201320.","journal-title":"Cell Mol. Life Sci."},{"key":"18091281_CR46","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/leu.2008.379","volume":"23","author":"E Kostareli","year":"2009","unstructured":"Kostareli E, et al. (2009) Molecular evidence for EBV and CMV persistence in a subset of patients with chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors. Leukemia 23:919\u201324.","journal-title":"Leukemia"},{"key":"18091281_CR47","doi-asserted-by":"publisher","first-page":"4460","DOI":"10.1182\/blood-2009-05-221309","volume":"114","author":"LA Sutton","year":"2009","unstructured":"Sutton LA, et al. (2009) Extensive intraclonal diversification in a subgroup of chronic lymphocytic leukemia patients with stereotyped IGHV4-34 receptors: implications for ongoing interactions with antigen. Blood. 114:4460\u201368.","journal-title":"Blood"},{"key":"18091281_CR48","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1084\/jem.20040544","volume":"200","author":"BT Messmer","year":"2004","unstructured":"Messmer BT, et al. (2004) Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J. Exp. Med. 200:519\u201325.","journal-title":"J. Exp. Med."},{"key":"18091281_CR49","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.3324\/haematol.2009.021014","volume":"95","author":"M Marincevic","year":"2010","unstructured":"Marincevic M, et al. (2010) High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with \u2018stereotyped\u2019 IGHV3\u201321 and IGHV4\u201334 B-cell receptors. Haematologica. 95:1519\u201325.","journal-title":"Haematologica"},{"key":"18091281_CR50","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.3324\/haematol.2010.028639","volume":"95","author":"M Marincevic","year":"2010","unstructured":"Marincevic M, et al. (2010) Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4\u201334 B-cell receptors. Haematologica. 95:2072\u20139.","journal-title":"Haematologica"},{"key":"18091281_CR51","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/sj.leu.2404456","volume":"21","author":"DE Spaner","year":"2007","unstructured":"Spaner DE, Masellis A. (2007) Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia Leukemia. 21:53\u201360.","journal-title":"Leukemia"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2011.00480.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.2119\/molmed.2011.00480\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.crossref.org\/molmed.2011.00480","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2011.00480.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:45:45Z","timestamp":1595205945000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/molmed.2011.00480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,19]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["18091281"],"URL":"https:\/\/doi.org\/10.2119\/molmed.2011.00480","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,19]]}}}